Zinc for the common cold? The industry responds.
18:12 EDT 14 Jul 2012 | Forbes
The CEO and chief scientist at the company that makes Cold-EEZE, a zinc-based treatment for the common cold, sent a detailed response to a recent Salzberg blog article. Here it is, with commentary.
Original Article: Zinc for the common cold? The industry responds.
More From BioPortfolio on "Zinc for the common cold? The industry responds."
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
